ACRUX LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.061 AUD | +1.67% |
|
+1.67% | +38.64% |
| Apr. 03 | Acrux, TruPharma Launch Dapsone 5% Gel in US | MT |
| Feb. 29 | Transcript : Acrux Limited, H1 2024 Earnings Call, Feb 29, 2024 |
Presenter SpeechMichael Kotsanis (Executives)Well, good morning, and I appreciate everyone tha...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Acrux Limited is an Australia-based specialty pharmaceutical company. The Company is engaged in developing and commercializing a pipeline of topically applied pharmaceutical products. Its products include Lidocaine and Prilocaine Cream, USP 2.5%/2.5%, Lenzetto, Evamist and Testosterone Topical Solution, 30 mg / 1.5 ml. Lidocaine and Prilocaine Cream USP (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anesthetic for use on normal intact skin for local analgesia and genital mucous membranes for superficial minor surgery and as pretreatment for infiltration anesthesia. Lenzetto(estradiol 1.53 mg/spray, transdermal spray, solution) is an estradiol spray for women which is used to treat moderate to severe hot flushes commonly associated with menopause. Testosterone Topical Solution is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.
Sector
Pharmaceuticals
Calendar
2024-08-22
- Q4 2024 Earnings Release (Projected)
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +38.64% | 11.38M | |
| +20.81% | 43.34B | |
| +20.44% | 21.96B | |
| +11.57% | 14.09B | |
| +12.97% | 13.64B | |
| +39.74% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
- Stock Market
- Equities
- ACR Stock
- News Acrux Limited
- Transcript : Acrux Limited, H1 2024 Earnings Call, Feb 29, 2024
